×
For best experience we recommend to activate Javascript in your browser.
DALRD3 antibody (AA 182-481) (Biotin)
The Biotin-conjugated Rabbit Polyclonal anti-DALRD3 antibody (ABIN7149481) specifically detects DALRD3 in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7149481
$335.48
$394.68
save $59.20 (-15 %)
Plus shipping costs $50.00
50 μg ABIN7354937
100 μg ABIN7149481
50 μg ABIN7354937
100 μg ABIN7149481
Delivery in 13 to 16 Business Days
Quick Overview for DALRD3 antibody (AA 182-481) (Biotin) (ABIN7149481)
Target
See all DALRD3 Antibodies
DALRD3
(DALR Anticodon Binding Domain Containing 3 (DALRD3))
Reactivity
All reactivities for DALRD3 antibodies
Human
Host
All hosts for DALRD3 antibodies
Rabbit
Clonality
All clonalities for DALRD3 antibodies
Polyclonal
Conjugate
All conjugates for DALRD3 antibodies
This DALRD3 antibody is conjugated to Biotin
Application
All applications for DALRD3 antibodies
ELISA
Product Details anti-DALRD3 Antibody (Biotin)
(hide)
Binding Specificity
All epitopes for DALRD3 antibodies
AA 182-481
Purpose
DALRD3 Antibody, Biotin conjugated
Purification
Protein G purified
Purity
>95 %
Immunogen
Recombinant Human DALR anticodon-binding domain-containing protein 3 protein (182-481AA)
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Preservative: 0.03 % Proclin 300 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Details for DALRD3
(hide)
Target
DALRD3
(DALR Anticodon Binding Domain Containing 3 (DALRD3))
Alternative Name
DALRD3
Background
DALRD3DALR anticodon-binding domain-containing protein 3 antibody
UniProt
Q5D0E6
Recently viewed
(hide)
Chat with us , powered by LiveChat